Fedha

Hisa unazofuatilia
601607:SHA
Shanghai Pharmaceuticals Holding Ord Shs A
CN¥ 16.61
-0.89%
(-0.15) Siku 1
16 Okt, 15:00:02 GMT +8  ·   CNY
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya 601607...
Fungua
CN¥ 16.71
Juu
CN¥ 16.91
Chini
CN¥ 16.52
Mtaji wa soko
55.57B
Wastani wa kiasi cha mauzo
9.85M
Kiasi cha mauzo ya hisa
14.44M
Gawio
2.71%
Mgawo wa faida wa kila robo mwaka
CN¥ 0.11
Tarehe ya kutojumuisha gawio
18 Sep 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
12.90
Juu kwa wiki 52
CN¥ 18.56
Chini kwa wiki 52
CN¥ 15.01
EPS
CN¥ 1.29
Hisa za wawekezaji
1.92B
Idadi ya wafanyakazi
elfu 49
Fungua
CN¥ 16.71
Juu
CN¥ 16.91
Chini
CN¥ 16.52
Mtaji wa soko
55.57B
Wastani wa kiasi cha mauzo
9.85M
Kiasi cha mauzo ya hisa
14.44M
Gawio
2.71%
Mgawo wa faida wa kila robo mwaka
CN¥ 0.11
Tarehe ya kutojumuisha gawio
18 Sep 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
12.90
Juu kwa wiki 52
CN¥ 18.56
Chini kwa wiki 52
CN¥ 15.01
EPS
CN¥ 1.29
Hisa za wawekezaji
1.92B
Idadi ya wafanyakazi
elfu 49
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets. Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list. Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Kuhusu Shanghai Pharmaceuticals Holding Ord Shs A
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 48.6
Lilianzishwa18 Jan 1994
Makao makuu-
SektaHealth care provider
Ripoti za awaliThamani zote katika CNY
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika CNY
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
73.48B
68.51B
75.26B
72.21B
Gharama ya bidhaa zilizouzwa
66.03B
60.55B
67.17B
64.09B
Gharama ya mapato
66.03B
60.55B
67.17B
64.09B
Gharama za utafiti na maendeleo
556.53M
824.53M
468.22M
502.64M
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
4.70B
4.97B
4.59B
4.65B
Gharama ya uendeshaji
5.58B
5.91B
5.47B
5.55B
Jumla ya gharama za uendeshaji
71.60B
66.47B
72.63B
69.64B
Mapato ya uendeshaji
1.88B
2.04B
2.63B
2.57B
Mapato mengine yasiyo ya uendeshaji
-84.84M
-63.65M
-47.88M
-7.43M
EBT ikijumuisha vipengee visivyo vya kawaida
1.48B
1.52B
2.42B
3.21B
EBT bila kujumuisha vipengee visivyo vya kawaida
1.61B
1.44B
2.27B
3.03B
Gharama ya kodi ya mapato
485.91M
534.14M
569.09M
720.64M
Kiwango cha kodi kinachotumika
32.89%
35.10%
23.52%
22.43%
Gharama nyingine za uendeshaji
129.62M
271.29M
132.16M
186.62M
Mapato halisi
688.20M
577.49M
1.42B
2.09B
Kiwango cha faida halisi
0.94%
0.84%
1.88%
2.89%
Mapato kwa kila hisa
-
-
-
-
Mapato ya riba na uwekezaji
206.57M
-
38.70M
873.52M
Gharama ya riba
-393.02M
-470.36M
-347.64M
-358.39M
Jumla ya gharama halisi za riba
-186.45M
-470.36M
-308.94M
515.13M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
2.26B
2.54B
3.12B
3.07B
Faida au hasara kutokana na uuzaji wa vipengee
39.99M
-157.15M
-
-179.70M
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google